Rachel Chiaverelli, PhD, has joined GSK as Executive Director, Oncology Early Translational Biomarkers, after nearly four ...
Merck, known as MSD outside the U.S. and Canada, launched Your Hive of Whole Health on September 18, 2026 — a multi-year ...
OS Therapies Aligns With FDA on Phase 3 Design, Accepts MHRA’s Project Orbis Invitation for OST-HER2
OS Therapies, Inc., a Rockville, Maryland- and New York-based clinical-stage oncology company, announced on September 17, ...
Velocity Clinical Research has appointed Justin Starzyk as Chief Executive Officer, succeeding Paul Evans, who is ...
Claritev has appointed Ben Letham to its Board of Directors, effective September 14, 2026. “Claritev is fortunate to add a ...
Georgiamune, a Gaithersburg, Maryland-based clinical-stage biotech with roughly 30 employees, is reported to be raising approximately $93 million in Series B financing to advance its cancer and ...
Penn Medicine has named Julia Puchtler Executive Vice President and Chief Financial Officer of the University of Pennsylvania Health System (UPHS), ...
Autolus Therapeutics plc, the commercial-stage biopharmaceutical company with dual headquarters in London and Gaithersburg, Maryland, announced on September 9, 2026 that the FDA granted Regenerative ...
The University of Maryland School of Public Health announced on September 15, 2026 a $2.5 million grant from the National Institutes of Health to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results